Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.38
+0.01500.64%
Post-market: 2.37-0.0050-0.21%17:10 EDT
Volume:112.39K
Turnover:270.47K
Market Cap:68.55M
PE:-1.54
High:2.45
Open:2.38
Low:2.35
Close:2.36
Loading ...
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Correspondence

Form CORRESP - Correspondence
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Oct 26, 2023

Major Issues Report

Form 8-K - Current report